Immune Checkpoint Inhibitor-Induced Reinvigoration of Tumor-Infiltrating CD8+ T Cells Is Determined by Their Differentiation Status in Glioblastoma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-2564
Full Text
Open PDFAbstract
Available in full text
Date
January 18, 2019
Authors
Publisher
American Association for Cancer Research (AACR)